U. S. Securities and Exchange Commission
                            Washington, D.C.   20549

                                   FORM 10-QSB
(Mark One)

[X]     QUARTERLY  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  SECURITIES
        EXCHANGE  ACT  OF  1934

For  the  quarter  ended  July 31, 2001
                          -------------

[ ]     TRANSITION  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  SECURITIES
        EXCHANGE  ACT  OF  1934

For  the  transition  period  from ____________________ to ____________________

Commission  File  No.  000-32089
                       ---------

                                 FAR GR0UP INC.
                    ----------------------------------------
                 (Name of Small Business Issuer in its Charter)

Washington                                                            91-2023071
----------                                                            ----------
(State or Other Jurisdiction of                                 (I.R.S. Employer
incorporation or organization)                                Identification No)

                          Suite 210, 580 Hornby Street
                  Vancouver, British Columbia, Canada V6C 3B6
                  -------------------------------------------
                    (Address of Principal Executive Offices)

                                 (604) 662-7000
                          ----------------------------
                            Issuer's Telephone Number

                                       N/A
                          ----------------------------
          (Former Name or Former Address, if changed since last Report)

Check  whether  the Issuer (1) filed all reports required to be filed by Section
13  or  15(d) of the Exchange Act during the past 12 months (or for such shorter
period  that  the  Company  was required to file such reports), and (2) has been
subject  to  such  filing  requirements  for  the  past  90  days.
      (1)  Yes    X    No       (2)  Yes     X     No
                 ---       ---              ---        ---

     (ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)

                                 Not applicable

                     (APPLICABLE ONLY TO CORPORATE ISSUERS)

State the number of shares outstanding of each of the Issuer's classes of common
equity,  as  of  the  latest  practicable  date:

                                  July 31, 2001

     Common - 2,600,000 common shares (See Note 7(b) of the Interim Financial
                     Statements attached as Part I Item 1).

                       DOCUMENTS INCORPORATED BY REFERENCE

A  description of any "Documents Incorporated by Reference" is contained in Item
6  of  this  Report.

    Transitional Small Business Issuer Format     Yes  X          No
                                                      ---             ---


<PAGE>
PART  I  -  FINANCIAL  INFORMATION

Item  1.    Financial  Statements.

The  Financial  Statements  of the Company required to be filed with this 10-QSB
Quarterly Report were prepared by management and commence on the following page,
together  with  related  Notes.  In  the  opinion  of  management, the Financial
Statements  fairly  present  the  financial  condition  of  the  Company.

                                 FAR GROUP INC.
                          (A Development Stage Company)
                          INTERIM FINANCIAL STATEMENTS
                                  JULY 31, 2001
                                   (Unaudited)


<PAGE>
<TABLE>
<CAPTION>
FAR  Group,  Inc.
(A Development Stage Company)
Interim  Balance  Sheet

                                                                                July 31,    April 30,
                                                                                    2001         2001
                                                                                       $            $
                                                                             (unaudited)    (audited)
<S>                                                                          <C>           <C>
ASSETS

Current Assets

Cash                                                                                 207        2,361
------------------------------------------------------------------------------------------------------

Total Assets                                                                         207        2,361
======================================================================================================


LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities

Accounts payable                                                                   6,856        4,199
Accrued liabilities                                                                  500          750
Note payable (Note 4)                                                             35,000       35,000
------------------------------------------------------------------------------------------------------

Total Liabilities                                                                 42,356       39,949
------------------------------------------------------------------------------------------------------

Contingency (Note 1)

Stockholders' Equity (Deficit)

Common Stock: $0.0001 par value; authorized 100,000,000 common shares;
2,600,000 shares issued and outstanding respectively (Note 7(b)                      260          260

Additional Paid-in Capital                                                        25,740       25,740
------------------------------------------------------------------------------------------------------
                                                                                  26,000       26,000
------------------------------------------------------------------------------------------------------
Preferred Stock: $.0001 par value; authorized 20,000,000 preferred shares;
none issued                                                                            -            -
------------------------------------------------------------------------------------------------------
Deficit Accumulated During the Development Stage                                 (68,149)     (63,588)
------------------------------------------------------------------------------------------------------
Total Stockholders' Deficiency                                                    42,149      (37,588)
------------------------------------------------------------------------------------------------------
Total Liabilities and Stockholders' Equity (Deficiency)                              207        2,361
======================================================================================================
</TABLE>

(See  Accompanying  Notes  to  the  Interim  Financial  Statements)


                                      F-1
<PAGE>
<TABLE>
<CAPTION>
FAR  Group,  Inc.
(A  Development  Stage  Company)
Interim  Statements  of  Operations

                                                  Accumulated From
                                                    March 24, 2000        Three months ended
                                                (Date of Inception)     July 31,      July 31,
                                                  to July 31, 2001          2001          2000
                                                                 $             $             $
                                                        (unaudited)   (unaudited)   (unaudited)
<S>                                             <C>                   <C>           <C>
Revenue                                                           -             -              -
------------------------------------------------------------------------------------------------


Expenses

Accounting and legal                                         23,806         3,255              -
Bank charges                                                     55            10              -
Consulting fees                                               5,000             -              -
License written-off                                          35,000             -              -
Office                                                        1,100           438              -
Transfer agent and filing fees                                3,188           858              -
------------------------------------------------------------------------------------------------
Net loss                                                    (68,149)       (4,561)             -
================================================================================================
Net Loss Per Share (Basic and diluted)                                          -              -
================================================================================================
Weighted Average Number of Shares Outstanding                           2,600,000      1,600,000
================================================================================================
</TABLE>

(See Accompanying Notes to the Interim Financial Statements)


                                      F-2
<PAGE>
<TABLE>
<CAPTION>
FAR  Group,  Inc.
(A  Development  Stage  Company)
Interim  Statements  of  Cash  Flows

                                                                             Three months ended
                                                                           July 31,      July 31,
                                                                               2001          2000
                                                                                  $             $
                                                                         (unaudited)   (unaudited)
<S>                                                                      <C>           <C>

Cash Flows From Operating Activities

Net loss                                                                      (4,561)             -

Items not requiring outlay of cash:

Legal and organizational costs                                                     -              -
License written-off                                                                -              -

Changes in operating assets and liabilities:

Accounts payable and accrued liabilities                                       2,407              -
---------------------------------------------------------------------------------------------------
Net Cash Used by Operating Activities                                         (2,154)             -
---------------------------------------------------------------------------------------------------

Cash Flows From Financing Activities

Common shares issued                                                               -              -
---------------------------------------------------------------------------------------------------
Decrease In Cash                                                              (2,154)             -

Cash at Beginning of Period                                                    2,361              -
---------------------------------------------------------------------------------------------------
Cash at End of Period                                                            207              -
===================================================================================================

Non-Cash Financing Activities

A total of 1,600,000 shares were issued to a director at a fair market
value of $0.01 per share for legal and organizational expenses paid                -              -

A note payable was assumed by the Company for the acquisition of a
License from a director (Notes 3 and 5)                                            -              -
---------------------------------------------------------------------------------------------------

                                                                                   -              -
===================================================================================================

Supplemental Disclosures

Interest paid                                                                      -              -
Income tax paid                                                                    -              -
</TABLE>

(See Accompanying Notes to the Interim Financial Statements)


                                      F-3
<PAGE>
FAR  Group,  Inc.
A  Development  Stage  Company)
Notes to the Interim Financial Statements
July  31,  2001
(unaudited)


1.   Development  Stage  Company

     FAR  Group,  Inc.  herein  (the "Company") was incorporated in the State of
     Washington,  U.S.A.  on  March  24, 2000. The Company acquired a license to
     market  and  distribute  vitamins,  minerals,  nutritional supplements, and
     other  health  and  fitness  products  in  which the grantor of the license
     offers  these  products  for sale from various suppliers on their Web Site.

     The  Company  is  in the development stage. In a development stage company,
     management  devotes  most  of its activities in developing a market for its
     products.  Planned  principal activities have not yet begun. The ability of
     the  Company  to  emerge  from  the  development  stage with respect to any
     planned  principal  business  activity  is  dependent  upon  its successful
     efforts  to  raise  additional  equity  financing  and/or attain profitable
     operations.  There  is  no guarantee that the Company will be able to raise
     any  equity  financing  or  sell  any of its products at a profit. There is
     substantial  doubt  regarding  the Company's ability to continue as a going
     concern.

     The  Company  filed an SB-2 Registration Statement with the U.S. Securities
     Exchange  Commission  which  was  declared  effective  in January 2001. The
     Company sold and issued 1,000,000 common shares at $0.01 per share for cash
     proceeds of $10,000. The Company trades on the OTC Bulletin Board under the
     symbol  FGRI.


2.   Summary  of  Significant  Accounting  Policies

     (a)  Year  end

          The Company's fiscal year end is April 30.

     (b)  License

          The cost to acquire the License was capitalized. The carrying value of
          the  License  is  evaluated  in  each reporting period to determine if
          there  were  events  or  circumstances which would indicate a possible
          inability  to recover the carrying amount. Such evaluation is based on
          various  analyses  including  assessing the Company's ability to bring
          the  commercial  applications  to  market,  related  profitability
          projections  and  undiscounted cash flows relating to each application
          which  necessarily  involves significant management judgment. Where an
          impairment  loss  has  been  determined  the  carrying  amount  is
          written-down  to fair market value. Fair market value is determined as
          the amount at which the license could be sold in a current transaction
          between  willing  parties.  The  License  has  been  written-off  to
          operations  due to the lack of historical cash flow of the license and
          lack  of  a  market  to  resell  the  license.

     (c)  Cash  and  Cash  Equivalents

          The Company considers all highly liquid instruments with a maturity of
          three  months  or less at the time of issuance to be cash equivalents.

     (d)  Revenue  Recognition

          The  Company will receive from the Grantor of the license, commissions
          of  one-half of all the profit on all sales made through the Grantor's
          Web  Site. The commission revenue will be recognized in the period the
          sales have occurred. The Company will report the commission revenue on
          a  net  basis as the Company is acting as an Agent for the Grantor and
          does not assume any risks or rewards of the ownership of the products.
          This  policy  is  prospective  in  nature  as  the Company has not yet
          generated  any  revenue.


                                      F-4
<PAGE>
2.   Summary  of  Significant  Accounting  Policies

     (e)  Use  of  Estimates

          The  preparation  of financial statements in conformity with generally
          accepted  accounting  principles requires management to make estimates
          and  assumptions  that  affect  the  reported  amounts  of  assets and
          liabilities and disclosure of contingent assets and liabilities at the
          date  of the financial statements and the reported amounts of revenues
          and  expenses  during  the  periods.  Actual results could differ from
          those  estimates.

     (f)  Interim  Financial  Statements

          These interim unaudited financial statements have been prepared on the
          same  basis  as  the annual financial statements and in the opinion of
          management,  reflect  all  adjustments,  which  include  only  normal
          recurring  adjustments,  necessary  to  present  fairly  the Company's
          financial  position,  results  of  operations  and  cash flows for the
          periods  shown.  The  results  of  operations for such periods are not
          necessarily  indicative of the results expected for a full year or for
          any  future  period.


3.   License

     The  Company's asset is a license to market vitamins, minerals, nutritional
     supplements and other health and fitness products through the Grantor's Web
     Site.  The  Company  desires  to  market  these  products  to  medical
     practitioners,  alternative  health professionals, martial arts studios and
     instructors,  sports  and  fitness  trainers,  other  health  and  fitness
     practitioners,  school  and  other  fund raising programs and other similar
     types of customers in Minnesota. The license was acquired on April 13, 2000
     for  a  term of three years. The Company must pay an annual fee of $500 for
     maintenance  of  the Grantor's Web Site commencing on the anniversary date.
     The  Grantor  of  the  license  retains  50%  of  the  profits.

     The Company paid total consideration of $35,000 for the license with a note
     payable  of  $35,000.  See  Note  5.

     The  License  has  been  written-off  to  operations  due  to  the  lack of
     historical  cash  flow and lack of a market to resell the license. However,
     it  is  the  Company's  intention to conduct a survey to determine its core
     target  market  from  amongst  the  potential  clients  under  its
     Vitamineralherb.com  license,  hire  commissioned sales staff, establish an
     office,  advertise,  and  begin  making  sales.


4.   Note  Payable

     The  note  payable is unsecured, non-interest bearing and is repayable upon
     the successful completion of an Initial Public Offering of the common stock
     of the Company and sale of all registered shares pursuant to such offering.
     As  the  proceeds  from this offering are not sufficient to repay this loan
     the  President  of  the  Company  does not intend to demand repayment until
     sufficient  funds  are  in  place.


5.   Related  Party  Transaction

     The  License  referred to in Note 4 was assigned to the Company by the sole
     director  and  President of the Company for consideration of the assumption
     of  a  note payable of $35,000. The License was recorded at the transferors
     cost  of  $35,000  which  was  also  fair  market  value  at  the  time.

     The  Grantor  of  the  License  is  not  related  to  the  Company.


6.   Commitment

     The  Company  entered into a Business Agreement with Magnum Financial Corp.
     ("Magnum")  whereby  Magnum  will  assist  the Company with the approval of
     trading  on  the  OTC  Bulletin  Board.  The  Company  has paid $5,000 upon
     acceptance  of  this agreement and will pay $5,000 upon listing for trading
     on the OTC BB and a further $5,000 three weeks after listing for trading on
     the  OTC BB. This agreement is to be cancelled and the amount owing will be
     waived.


                                      F-5
<PAGE>
7.   Subsequent  Events

     (a)  The  Company  has  paid  a  non-refundable fee of $10,000 to Equitrade
          Securities  Corporation  (an  investment  banking firm) pursuant to an
          agreement  dated  August  9,  2001.

     (b)  The  Company's  Board of Directors have approved a six for one forward
          split  with  a  record  date  of  August  31,  2001.

          A  total  of 15,600,000 common shares are issued and outstanding as at
          that  date.


                                      F-6
<PAGE>
Item  2.     Management's  Discussion  and  Analysis  or  Plan  of  Operation
-----------------------------------------------------------------------------

The  following  discussion  and  analysis of FAR Group's financial condition and
results  of  operations  should  be  read  in  conjunction  with  the  Financial
Statements  and accompanying notes and the other financial information appearing
elsewhere  in  this  report.

PLAN  OF  OPERATION
-------------------

During  the  period  from  March  24  2000  through July 31, 2001, FAR Group has
engaged  in  no  significant  operations  other  than organizational activities,
acquisition  of  the  rights  to  market  Vitamineralherb  and  preparation  for
registration  of its securities under the Securities Act of 1933, as amended. No
revenues  were  received  by  FAR  Group  during  this  period.

For  the  current  fiscal  year  ending  April  30,  2001, FAR Group anticipates
incurring  a  loss  as a result of expenses associated with setting up a company
structure  to  begin  implementing its business plan. FAR Group anticipates that
until  these  procedures  are  completed, it will not generate revenues, and may
continue  to operate at a loss thereafter, depending upon the performance of the
business.

FAR  Group's  business  plan  is  to  determine the feasibility of marketing the
Vitamineralherb products in various markets, and, if the products prove to be in
demand,  begin  marketing  and  selling  Vitamineralherb  products.

FAR Group remains in the development stage and, since inception, has experienced
no significant change in liquidity or capital resources or shareholders' equity.
Consequently,  FAR  Group's  balance  sheet  as of July 31, 2001, reflects total
assets  of  $207,  in  the  form  of  cash.

The  original  shareholder also paid for legal expenses in the amount of $16,000
for  which  he  received  1,600,000  shares  of  common  stock  of  the Company.

The  Company  filed  an  SB-2  Registration  Statement  with the U.S. Securities
Exchange  Commission  which  was declared effective in January 2001. The Company
sold  and issued 1,000,000 common shares at $0.01 per share for cash proceeds of
$10,000.  The  Company  trades  on the OTC Bulletin Board under the symbol FGRI.

FAR  Group's  business  plan  is  to  determine  the  feasibility  of  selling
Vitamineralherb.com  products  to  targeted  markets.  In order to determine the
feasibility of its business plan, FAR Group plans, during the next six to twelve
months,  to conduct research into these various potential target markets. Should
FAR  Group  determine  that the exploitation of the license is feasible, it will
engage  salespeople  to market the products. Based primarily on discussions with
the  licensor,  FAR Group believes that during its first operational quarter, it
will  need  a capital infusion of approximately $85,000 to achieve a sustainable
sales level where ongoing operations can be funded out of revenues. This capital
infusion  is  intended  to  cover  costs  of  advertising, hiring and paying two
salespeople,  and  administrative  expenses.  In  addition,  FAR Group will need
approximately  $260,000  in the event it determines that its market will not pay
in  advance  and  it  will  have to extend credit. FAR Group will have to obtain
additional  financing  through  an  offering or capital contributions by current
shareholders.

FAR  Group  will  need  additional  capital to carry out its business plan or to
engage  in  a  business  combination. No commitments to provide additional funds
have been made by management or other shareholders. Accordingly, there can be no
assurance that any additional funds will be available on terms acceptable to FAR
Group  or  at  all.  FAR  Group  has  no  commitments  for capital expenditures.

In  addition,  FAR  Group may engage in a combination with another business. FAR
Group has engaged in discussions concerning potential business combinations, but
has  not  entered  into  any  agreement  for  such  a  combination.

The  Company  has  paid  a non-refundable fee of $10,000 to Equitrade Securities
Corporation  (an  investment banking firm) pursuant to an agreement dated August
9,  2001.

The  Company's Board of Directors have approved a six for one forward split with
a record date of August 31, 2001. A total of 15,600,000 common shares are issued
and  outstanding  as  at  that  date.

FAR  Group's  failure  to  generate  revenues  and  conduct operations since its
inception  raise  substantial  doubt  about FAR Group's ability to continue as a
going concern. FAR Group will require substantial working capital, and currently
has  inadequate  capital  to fund its business. FAR Group may be unable to raise
the  funds  necessary  for  implementing its business plan, which could severely
limit  its  operations  and  cause  its  stock  to  be  worthless.


                                      F-7
<PAGE>
PART  II  -  OTHER  INFORMATION

Item  1.  Legal  Proceedings.

          None;  not  applicable.

Item  2.  Changes  in  Securities.

          None;  not  applicable.

Item  3.  Defaults  Upon  Senior  Securities.

          None;  not  applicable.

Item  4.  Submission  of  Matters  to  a  Vote  of  Security  Holders.

          None;  not  applicable.

Item  5.  Other  Information.

          None;  not  applicable.

Item  6.  Exhibits  and  Reports  on  Form  8-K.

          None.


          DOCUMENTS  INCORPORATED  BY  REFERENCE

          None.


                                      F-8
<PAGE>
                                   SIGNATURES

Pursuant  to  the  requirements  of  the  Securities  Exchange  Act of 1934, the
Registrant  has  duly  caused  this  Report  to  be  signed on its behalf by the
undersigned  thereunto  duly  authorized.


                                     FAR  GROUP  INC.

Date:  September 11, 2001            By:  /s/  Frank  Roberts
                                          --------------------------------
                                          Frank Roberts, President,
                                          Secretary, Treasurer and
                                          Director


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
this  Report  has  been  signed  below by the following persons on behalf of the
Company  and  in  the  capacities  and  on  the  dates  indicated:


Date:  September  11,  2001          By:  /s/  Frank  Roberts
                                          --------------------------------
                                          Frank Roberts, President,
                                          Secretary, Treasurer and
                                          Director



                                      F-9
<PAGE>